Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis

Published:2022-03 Issue: Volume:919 Page:174792
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Sklepkiewicz Piotr,Dymek Barbara A.^ORCID,Mlacki Michal,Koralewski Robert,Mazur Marzena,Nejman-Gryz Patrycja^ORCID,Korur Serdar,Zagozdzon Agnieszka,Rymaszewska Aleksandra,von der Thüsen Jan H.,Siwińska Anna M.,Güner Nazan Cemre,Cheda Łukasz,Paplinska-Goryca Magdalena^ORCID,Proboszcz Małgorzata^ORCID,van den Bosch Thierry P.P.,Górska Katarzyna,Golab Jakub,Kamiński Rafał M.,Krenke Rafał^ORCID,Golebiowski Adam,Dzwonek Karolina,Dobrzanski Pawel

Publisher

Elsevier BV

Subject

Pharmacology

Reference49 articles.

1. Macrophage chitinase 1 stratifies chronic obstructive lung disease;Agapov;Am. J. Respir. Cell Mol. Biol.,2009

2. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage;Aran;Nat. Immunol.,2019

3. Chitotriosidase activity in patients with interstitial lung diseases;Bargagli;Respir. Med.,2007

4. Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib;Bellamri;Int. Immunopharm.,2019

5. Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis;Bennett;Respir. Res.,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal relationship between serum metabolites and idiopathic pulmonary fibrosis: Insights from a two-sample Mendelian randomization study;Heliyon;2024-08

2. Exploring CHIT1 and YKL-40 in tuberculous pleural effusion: insights and implications;2024-07-13

3. Multiomic analysis of monocyte-derived alveolar macrophages in idiopathic pulmonary fibrosis;Journal of Translational Medicine;2024-06-27

4. Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases;Frontiers in Immunology;2024-03-14

5. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14